In cases of cholestatic liver disease, BM-MSCs mitigated the activation of hepatic stellate cells (HSCs) through the regulation of autophagy via the PI3K/AKT/mTOR pathway [64]. This evidence concerns the gene MTOR and Cholestatic liver disease.